Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.
Beatrix Vereijken and Lynn Rochester share how Mobilise-D develops digital technology to measure mobility in daily life to transform clinical research and health.
Professor of Evolutionary Biology Ashleigh S. Griffin discusses harnessing the power of evolutionary process instead of fighting it, particularly regarding bacterial cells and cooperation.
Andrew Nunn, Professor of Epidemiology, Medical Research Council Clinical Trials Unit at UCL, describes the first phase 3 trial of a shortened treatment for MDR-TB.
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
